Advanced search
Publication Cover
Immunopharmacology and Immunotoxicology Volume 31, 2009 - Issue 2
Submit an article Journal homepage
81
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Protection with a recombinant Hc of Clostridium Botulinum neurotoxin serotype A from Escherichia coli as an effective subunit vaccine

Yun-Zhou YuBeijing Institute of Biotechnology, Beijing, China
,
Zhi-Wei SunBeijing Institute of Biotechnology, Beijing, China
,
Na LiBeijing Institute of Biotechnology, Beijing, China
,
Shuang WangBeijing Institute of Biotechnology, Beijing, China
,
Rui-Lin WangBeijing Institute of Biotechnology, Beijing, China
&
Wei-Yuan YuBeijing Institute of Biotechnology, Beijing, ChinaCorrespondence[email protected]
Pages 261-266 | Received 29 Jul 2008, Accepted 16 Aug 2008, Published online: 01 Jun 2009

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Na Li, Yun-Zhou Yu, Wei-Yuan Yu & Zhi-Wei Sun. (2011) Enhancement of the immunogenicity of DNA replicon vaccine of Clostridium botulinum neurotoxin serotype A by GM-CSF gene adjuvant. Immunopharmacology and Immunotoxicology 33:1, pages 211-219.
Read now

Articles from other publishers (2)

David M. White, Sabine Pellett, Mark A. Jensen, William H. Tepp, Eric A. Johnson & Barry G. W. Arnason. (2011) Rapid Immune Responses to a Botulinum Neurotoxin Hc Subunit Vaccine through In Vivo Targeting to Antigen-Presenting Cells . Infection and Immunity 79:8, pages 3388-3396.
Crossref
Yun-Zhou Yu, Zheng-Wei Gong, Yao Ma, Shu-Ming Zhang, Heng-Qi Zhu, Wen-Bing Wang, Yun Du, Shuang Wang, Wei-Yuan Yu & Zhi-Wei Sun. (2011) Co-expression of tetanus toxin fragment C in Escherichia coli with thioredoxin and its evaluation as an effective subunit vaccine candidate. Vaccine 29:35, pages 5978-5985.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.